IWK approach to treating preterm infants with PDA being studied across North America

For immediate release – September 2, 2021

Halifax -IWK Health is reporting the first use of high dose ibuprofen in North America to treat patent ductus arteriosus (PDA) a common heart problem which occurs most often in extremely premature infants. In a paper published in the Journal of Perinatology the treatment shows a 21 per cent reduction in the need for the risky heart surgery. 

Study finds flu vaccine during pregnancy does not adversely affect early childhood health

Halifax - Researchers at IWK Health, in partnership with leading vaccine and infectious diseases researchers, have found that maternal influenza vaccination during pregnancy is not significantly associated with an increased risk of adverse early childhood health outcomes. Continue Reading